SIOX - Sio Gene Therapies trades high on receiving $11.6M on Arvelle Therapeutics sale closure
Sio Gene Therapies (SIOX) rallied 7.4% premarket on receiving $11.6M from the closing of the sale of Arvelle Therapeutics to Angelini Pharma.Under sale terms, additional payments to Sio Gene Therapies are expected over time, including a payment of ~$4.8M by mid-2021 upon marketing approval of cenobamate by the European Medicines Agency.
For further details see:
Sio Gene Therapies trades high on receiving $11.6M on Arvelle Therapeutics sale closure